A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Clinical trial NCT02120898 · COMPLETED

Trial details

NCT number: NCT02120898
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2013-10-10
Primary completion: 2014-04-30
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.